Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/2003
12/03/2003EP1365753A2 Uroguanylin and cyclooxygenase-2 inhibitor combinations for inhibition of intestinal cancer
12/03/2003EP1257555B1 Pyrimidine compounds and their use as modulators of chemokine receptor activity
12/03/2003EP1224181B1 Substituted pyrroles as antiproliferative agents for the treatment of cancer
12/03/2003EP1161417B1 Methods and compositions for treating leukemia
12/03/2003EP1123301B1 Chelating agents for radioimmunotherapy
12/03/2003EP1117659B1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
12/03/2003EP1115427B1 Time-staggered utilization of tumor cells in combination with intact antibodies for immunization
12/03/2003EP0971702B1 Microgranules containing cisplatin
12/03/2003EP0937070B1 Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
12/03/2003EP0687295B1 Human b-lymphoblastoid cell line secreting anti-ganglioside antibody
12/03/2003CN1460109A Improved specificity in treatment of diseases
12/03/2003CN1460108A Water soluble rapamycin esters
12/03/2003CN1460105A 黄嘌呤磷酸二酯酶v抑制剂 Xanthine phosphodiesterase inhibitor v
12/03/2003CN1460101A Novel compounds inhibiting factor Xa activity
12/03/2003CN1460099A Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
12/03/2003CN1460024A Use of FVIIa or tissue factor antagonist for regulating gene expression and cell migration or chemotaxis
12/03/2003CN1460023A Polymer-modified bioactive sythetic chemokines, and method for their mfg. and use
12/03/2003CN1459459A Preparation and assaying of peptide dextran possessing detectable oral absorption immune regulation of rainbow conk
12/03/2003CN1459280A Usage of immunopotentiation by using resveratrol
12/03/2003CN1129667C Autoimmune cell for treating tumor and its preparing process
12/03/2003CN1129606C Heptapeptide oxytocin analogues
12/03/2003CN1129603C Heterocycles, its preparation, application and medicine contanining same
12/03/2003CN1129597C Heterocyclic compounds and antitumor agent containing same as active ingredient
12/03/2003CN1129577C 维生素d3衍生物 Derivatives of vitamin d3
12/03/2003CN1129576C Phenyl heterocyclic compound used as epoxy enzyme-2 inhibitor
12/03/2003CN1129432C Reducing toxic effects of carboplatin using dithioethers
12/03/2003CN1129431C Combination of benzocyclobeptapyridine compounds and antineoplastic drugs for treating proliferative diseases
12/03/2003CA2409795A1 Liposome preparation
12/02/2003US6657047 Nucleotide sequences coding polypeptide for use in the treatment of tumors, inflammation, psoriasis, rheumatoid arthritis, cardiovascular and vision disorders
12/02/2003US6656971 Non-peptidic small organic compounds having an affinity for cyclophilin (CyP)-type immunophilins; inhibiting their peptidyl-prolyl isomerase activity; treating variety of medical conditions
12/02/2003US6656966 Nitrosated and nitrosylated taxanes, compositions and methods of use
12/02/2003US6656964 Reducing levels of tumor necrosis factor alpha; inhibition of undesireable levels of matrix metalloproteinases
12/02/2003US6656955 Side effect reduction; synergistic mixture
12/02/2003US6656954 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity
12/02/2003US6656949 4-anilinofuro [3,2-c] quinoline derivatives, and preparation processes and uses of the same
12/02/2003US6656942 Orally active salts with tyrosine kinase activity
12/02/2003US6656939 Pyrazole compounds useful as protein kinase inhibitors
12/02/2003US6656938 Inducing cytokine biosynthesis in animals, for the treatment of diseases, including viral and neoplastic diseases
12/02/2003US6656937 Substituted glutarimides and their use as inhibitors of IL-12 production
12/02/2003US6656932 Treating osteoarthritis, rheumatoid arthritis, cancer, inflammation, and heart failure
12/02/2003US6656926 Phosphoramide compounds
12/02/2003US6656905 Cyclic tetrapeptide compound and use thereof
12/02/2003US6656716 Polypeptide fragments of human PAK5 protein kinase
12/02/2003US6656713 Compounds and methods for modulating activation of NF-κB
12/02/2003US6656711 Fermentative preparation process for and crystal forms of cytostatics
12/02/2003US6656681 Polycystic kidney disease 12 gene and uses thereof
12/02/2003US6656482 Spill resistant pharmaceutical system
12/02/2003US6656462 Interleukin-1 muteins useful as vaccine adjuvants
12/02/2003US6656459 Compositions of non-ionic block copolymers to treat autoimmune and inflammatory diseases, and to reduce graft/implantation, and methods of use thereof
12/02/2003CA2284446C New cyclic cycloalkylene chain derivatives, their preparation process and pharmaceutical compounds containing them
11/2003
11/27/2003WO2003098223A2 A method for killing cells by inhibiting histone activity in the cell
11/27/2003WO2003097879A2 Method of identifying pancreatic ductal carcinoma-specific gene using pancreatic ductal cells, method of testing for pdc using said genes, and method of screening pharmaceutical candidate compounds for treating or preventing pdc
11/27/2003WO2003097872A2 G - protein coupled receptor marker molecules associated with colorectal lesions
11/27/2003WO2003097871A2 Marker molecules associated with lung tumors
11/27/2003WO2003097855A2 Small molecule inhibitors of her2 expression
11/27/2003WO2003097849A1 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor
11/27/2003WO2003097846A1 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
11/27/2003WO2003097845A1 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
11/27/2003WO2003097835A2 Pharmaceutical compositions for the treatment of cancer
11/27/2003WO2003097806A2 Substituted 4-aryl-4h-pyrrolo[2,3-h]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/27/2003WO2003097799A2 HTLV-I TAX INDUCED KILLING OF p53 NULL CANCER CELLS
11/27/2003WO2003097665A2 Mid 241 receptor, a novel g-protein coupled receptor
11/27/2003WO2003097658A2 Compounds and methods for inhibiting selectin-mediated function
11/27/2003WO2003097649A2 1-oxa-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
11/27/2003WO2003097647A1 Vitamin-mitomycin conjugates
11/27/2003WO2003097642A1 Anti-tumour polycyclic carboxamides
11/27/2003WO2003097641A2 1h-imidazo[4,5-c] quinoline derivatives in the treatment of protein kinase dependent diseases
11/27/2003WO2003097635A1 Processes for preparing 3-substituted 1-(chloromethyl)-1,2-dihydro-3h-[ring fused indol-5-yl(amine-derived)] compounds and analogues thereof, and to products obtained therefrom
11/27/2003WO2003097633A1 2-thio-substituted imidazole derivatives and their use in pharmaceutics
11/27/2003WO2003097625A1 Cytotoxic agents comprising polyethylene glycol-containing taxanes and their therapeutic use
11/27/2003WO2003097621A1 Methods of using thiazolidinedithione derivatives
11/27/2003WO2003097620A1 Thiazolidine-4-one derivative, method for preparing the same, and pharmaceutical composition containing the same
11/27/2003WO2003097610A1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
11/27/2003WO2003097609A1 N-substituted tricyclic 3-aminopyrazoles as pdfg receptor inhibitors
11/27/2003WO2003097608A2 Opioid and opioid-like compounds and uses thereof
11/27/2003WO2003097602A1 Cyanoguanidine produgs
11/27/2003WO2003097601A1 Cyanoguanidine prodrugs
11/27/2003WO2003097597A2 Indole derivatives and the use thereof as cb2 receptor ligands
11/27/2003WO2003097591A1 Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same
11/27/2003WO2003097586A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
11/27/2003WO2003097356A1 Camptothecin derivatives and polymeric conjugates thereof
11/27/2003WO2003097164A1 Use of docetaxel/doxorubicin/cyclophosphamide in adjuvant therapy of breast and ovarian cancer
11/27/2003WO2003097109A1 Improvements in delivery technology
11/27/2003WO2003097108A1 Medicinal formulation in particular for treating herniated invertebral discs
11/27/2003WO2003097105A1 Drug pre-targeting by means of bi-specific antibodies and hapten constructs comprising a carrier peptide and the active agent (s)
11/27/2003WO2003097104A1 Treatment and prevention of tissue damage
11/27/2003WO2003097101A1 Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activity
11/27/2003WO2003097098A1 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
11/27/2003WO2003097097A1 Method of treating and/or preventing acute leukemia using medicinal composition for therapeutic use containing vla4 antagonist, and method of diagnosing prognosis of acute leukemia using vla4 as indication
11/27/2003WO2003097076A1 Herbal formulations against adenocarcinoma of the prostate
11/27/2003WO2003097073A1 Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders
11/27/2003WO2003097068A1 Use of peroxovanadium compounds as tumour cell growth suppressor
11/27/2003WO2003097053A1 Compounds, compositions, and methods
11/27/2003WO2003097052A2 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
11/27/2003WO2003097051A2 Use of compounds that are effective as selective opiate receptor modulators
11/27/2003WO2003097048A1 Diaminothiazoles
11/27/2003WO2003097044A1 Methods using a combination of a 3-heteroaryl-2-indolinone and a cyclooxygenase-2 inhibitor for the treatment of neoplasia
11/27/2003WO2003097040A1 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
11/27/2003WO2003097035A1 Non-steroidal anti-androgen therapy
11/27/2003WO2003097034A1 TGF-α EXPRESSION INHIBITORS
1 ... 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 ... 2211